SCHEMBL28889308

SCHEMBL28889308

CNC(=O)SNC(=O)C(c1cc(C(F)(F)F)ccn1)c1ccccc1C

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 1/20 0.38
CTSA P10619 2/20 0.34
ALDH1A1 P00352 3/20 0.34
L3MBTL1 Q9Y468 3/20 0.34
GAA P10253 2/20 0.34
EPAS1 Q99814 1/20 0.33
TRPV3 Q8NET8 1/20 0.33
LMNA P02545 2/20 0.32
SORT1 Q99523 2/20 0.32
TRPV1 Q8NER1 1/20 0.32
POLB P06746 1/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
MAPT P10636 1/20 0.32
HTT P42858 1/20 0.32
RAB9A P51151 1/20 0.32
RIOK2 Q9BVS4 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
NR3C2 P08235 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28959159 0.90 ADRB2 (0.38) ADRB2ALDH1A1L3MBTL1GAAEPAS1
SCHEMBL28889336 0.90 HDAC4 (0.41) ADRB2CTSAALDH1A1L3MBTL1TRPV3
SCHEMBL28889204 0.89 ADRB2 (0.39) ADRB2ALDH1A1L3MBTL1EPAS1LMNA
SCHEMBL28889284 0.89 ADRB2 (0.37) ADRB2ALDH1A1L3MBTL1GAATRPV3
SCHEMBL29893753 0.89 ADRB2 (0.37) ADRB2ALDH1A1L3MBTL1GAATRPV3
SCHEMBL28889187 0.84 MEN1 (0.40) ADRB2CTSAALDH1A1L3MBTL1GAA
SCHEMBL28889237 0.83 ADRB2 (0.39) ADRB2ALDH1A1L3MBTL1GAASORT1
SCHEMBL28889194 0.83 ADRB2 (0.37) ADRB2ALDH1A1L3MBTL1GAALMNA
SCHEMBL29941794 0.82 ADRB2 (0.38) ADRB2CTSAALDH1A1L3MBTL1GAA
SCHEMBL28889339 0.80 ADRB2 (0.42) ADRB2CTSAALDH1A1L3MBTL1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115215862-A Pyrimidone compounds and uses thereof 武汉人福创新药物研发中心有限公司 2022-10-21 CN disclosed